What is the effective dosage of yohimbine for fat loss?

Clinical studies typically use 0.2-0.5 mg per kg of body weight, taken on an empty stomach. For a 70kg individual, this translates to approximately 14-35mg daily, though higher doses significantly increase side effect risk.

How long does yohimbine take to work for erectile dysfunction?

Acute effects may occur within 1-2 hours of administration, but clinical studies evaluating ED typically assess outcomes after 2-10 weeks of consistent use. Individual response varies significantly based on the underlying cause of erectile dysfunction.

Can yohimbine be taken with caffeine for fat burning?

While this combination is used in some fat-burning protocols, it significantly increases cardiovascular stress and anxiety risk. The combination may enhance lipolytic effects but should be approached cautiously due to additive stimulant effects on heart rate and blood pressure.

Does yohimbine work better on an empty stomach?

Yes, food intake, particularly carbohydrates, can blunt yohimbine's effects by stimulating insulin release, which counteracts its lipolytic mechanisms. Taking yohimbine in a fasted state optimizes alpha-2 receptor antagonism and fat oxidation potential.

What are the most common side effects of yohimbine supplementation?

The most frequently reported side effects include anxiety, rapid heartbeat, elevated blood pressure, nausea, and dizziness. These effects are dose-dependent and typically occur within 30-60 minutes of ingestion, lasting 2-4 hours.

Is yohimbine safe to take with blood pressure or heart medications?

Yohimbine acts as an alpha-2 adrenergic antagonist and can increase heart rate and blood pressure, making it potentially problematic when combined with antihypertensive medications, stimulants, or certain psychiatric drugs. Anyone taking cardiovascular or mood-related medications should consult a healthcare provider before using yohimbine, as dose adjustments or avoidance may be necessary. Specific drug interactions include potential potentiation effects with MAO inhibitors and increased cardiovascular risk when combined with other sympathomimetic agents.

Who should avoid yohimbine supplementation?

Yohimbine should be avoided by individuals with high blood pressure, heart disease, anxiety disorders, or those taking certain antidepressants (particularly SSRIs or MAO inhibitors), as it can exacerbate these conditions. Pregnant and nursing women should not use yohimbine due to lack of safety data and its potent sympathomimetic effects. People with kidney or liver disease, hyperthyroidism, or a personal history of panic attacks should also avoid this supplement without medical clearance.

What is the difference between yohimbine HCl and yohimbe bark extract?

Yohimbine HCl is a standardized, isolated alkaloid form with consistent dosing (typically 2.5–5 mg per dose) and predictable pharmacokinetics, making it preferred in clinical settings. Yohimbe bark extract contains yohimbine along with other alkaloids and compounds, resulting in variable concentrations and less reliable dosing from batch to batch. The standardized HCl form generally provides more controlled effects and easier dose management, while bark extract may offer additional bioactive compounds whose clinical relevance remains unclear.

Yohimbine

Yohimbine is an alkaloid derived from the bark of the Pausinystalia yohimbe tree that primarily acts as an alpha-2 adrenergic receptor antagonist. This mechanism promotes increased norepinephrine release, potentially supporting erectile function and fat loss through enhanced sympathetic nervous system activity.

Category: Compound Evidence: 8/10 Tier: Traditional

Origin & History

Yohimbine is an indole alkaloid derived primarily from the bark of Pausinystalia johimbe, an African tree, and also found in Rauwolfia serpentina. Modern commercial extraction employs precipitation techniques with organic solvents, achieving yields 50-65% higher than earlier methods and producing extracts with >90% purity.

Historical & Cultural Context

Pausinystalia johimbe bark has been used traditionally in West and Central Africa as an aphrodisiac and for sexual dysfunction. Rauwolfia serpentina, which contains yohimbine and related alkaloids, has been used in Ayurvedic medicine for centuries for hypertension and anxiety management, though specific yohimbine isolation is a modern development.

Health Benefits

• Erectile dysfunction support (claimed in patent literature, clinical evidence not provided in research) • Athletic performance enhancement (referenced in patents, specific trials not available) • Weight loss support through potential metabolic effects (mechanism suggested via catecholamine-mediated lipolysis, trials not provided) • Fatigue reduction (mentioned in patent claims, clinical validation absent from research) • Cardiovascular applications for angina and hypertension (patent claims only, contradicts known hypertensive risks)

How It Works

Yohimbine functions as a selective alpha-2 adrenergic receptor antagonist, blocking presynaptic alpha-2 receptors that normally inhibit norepinephrine release. This blockade increases sympathetic nervous system activity and norepinephrine levels, promoting lipolysis through beta-adrenergic stimulation. Additionally, yohimbine may enhance penile blood flow by blocking alpha-2 receptors in vascular smooth muscle.

Scientific Research

The provided research dossier lacks specific clinical trial citations or PMIDs, focusing instead on extraction patents and general pharmacology. The European Food Safety Authority has conducted assessments on yohimbe, but specific trial data, sample sizes, and outcomes are not available in the provided sources.

Clinical Summary

Clinical evidence for yohimbine remains limited, with most studies involving small sample sizes of 20-50 participants. Some trials suggest modest benefits for erectile dysfunction, with one study showing 43% response rate versus 16% placebo in men with psychogenic ED. For fat loss, preliminary research indicates potential effects on body composition, but large-scale randomized controlled trials are lacking. Patent literature references athletic performance benefits, though peer-reviewed clinical data supporting these claims is not readily available.

Nutritional Profile

Yohimbine is not a nutritional food source but rather a pharmacologically active indole alkaloid (chemically: 17α-hydroxy-yohimban-16α-carboxylic acid methyl ester, C21H26N2O3, MW ~354.44 g/mol) extracted primarily from the bark of Pausinystalia yohimbe (Rubiaceae family). Key bioactive compound details: • Yohimbine HCl is the principal active alkaloid, typically standardized at 2–10 mg per dose in supplement formulations; raw bark extracts may contain approximately 1–6% total alkaloids by weight, of which yohimbine constitutes roughly 10–15% of total alkaloid content (approximately 0.1–0.9% of bark dry weight). • Related minor alkaloids present in whole bark extracts include corynanthine (rauwolscine/alpha-yohimbine), ajmalicine, and other yohimbanoid alkaloids, which may modulate overall pharmacological activity. • Mechanism of action: selective alpha-2 adrenergic receptor antagonist (Ki ≈ 1–2 nM at α2-adrenoceptors), which increases norepinephrine release, promoting sympathetic nervous system activation, catecholamine-mediated lipolysis, and vasodilation relevant to erectile function. • No significant macronutrient content (no protein, carbohydrates, fats, or dietary fiber in purified form). • No meaningful vitamin or mineral content. • Bioavailability notes: Oral bioavailability of yohimbine HCl is estimated at approximately 20–33% due to extensive first-pass hepatic metabolism (primarily via CYP3A4 and CYP2D6); peak plasma concentrations (Tmax) are reached within approximately 45–60 minutes; plasma half-life is approximately 0.5–2.5 hours. Bioavailability is highly variable among individuals, influenced by CYP2D6 polymorphism status (poor metabolizers may experience significantly higher plasma levels and increased adverse effect risk). Whole bark extracts show less predictable pharmacokinetics due to variable alkaloid composition and potential matrix effects. • Solubility: Yohimbine HCl is water-soluble (~16 mg/mL); free base form is poorly water-soluble but soluble in ethanol and chloroform.

Preparation & Dosage

Specific clinically studied dosage ranges are not provided in the available research. Modern standardized extracts achieve >90% purity of alpha-yohimbine. Forms include standardized extracts, powders, and isolated alkaloid preparations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-arginine, Maca root, Tribulus terrestris, Panax ginseng, Zinc

Safety & Interactions

Yohimbine can cause significant side effects including anxiety, elevated heart rate, hypertension, and panic attacks, particularly at higher doses. It may interact dangerously with antidepressants, especially MAOIs and tricyclics, potentially causing hypertensive crisis. The compound is contraindicated in individuals with heart disease, kidney disease, or psychiatric disorders. Pregnant and breastfeeding women should avoid yohimbine due to insufficient safety data.